PARAXANTHINE DISPLACES THE BINDING OF [H-3] SCH-23390 FROM RAT STRIATAL MEMBRANES

被引:21
|
作者
FERRE, S
GUIX, T
SALLES, J
BADIA, A
PARRA, P
JANE, F
HERRERAMARSCHITZ, M
UNGERSTEDT, U
CASAS, M
机构
[1] HOSP SANTA CRUZ & SAN PABLO, DEPT FARMACOL CLIN, BARCELONA, SPAIN
[2] UNIV AUTONOMA BARCELONA, DEPT FARMACOL & PSIQUIAT, BARCELONA, SPAIN
[3] KAROLINSKA INST, DEPT PHARMACOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
Dopamine D-1 receptors; Methylxanthines; Paraxanthine; Striatum; [!sup]3[!/sup]H]SCH 23390;
D O I
10.1016/0014-2999(90)90168-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We present evidence showing that paraxanthine (1,7-dimethylxanthine), the main metabolite of caffeine in man, displaces the binding of [3H]SCH 23390, a radioligand which selectively labels dopamine D-1 receptors when used at low concentrations, from striatal membranes of the rat. The displacement was competitive and indicated the existence of two affinity states (Hill coefficient = 0.49; K(high) = 0.15 μM; K(low) = 95.9 μM, %R(high) = 32.4). When the stable GTP analog Gpp(NH)p was included, the displacement curve indicated the presence of only the low-affinity state (Hill coefficient = 1.16; Ki = 72.1 μM). However, paraxanthine did not displace the specific binding of [3H]spiperone. After injection of 30 mg/kg s.c. of caffeine, a maximum of 10 μM of paraxanthine was found in striatal homogenates, which could be sufficient to occupy dopamine D-1 receptors. Our results suggest that a dopaminergic action of paraxanthine could be involved in the behavioral stimulation produced by caffeine. © 1990.
引用
收藏
页码:295 / 299
页数:5
相关论文
共 50 条
  • [1] THE EFFECT OF BENZODIAZEPINES ON THE BINDING OF [H-3] SCH-23390 INVIVO
    INOUE, O
    KOBAYASHI, K
    SAKIYAMA, Y
    SUZUKI, T
    [J]. NEUROPHARMACOLOGY, 1992, 31 (02) : 115 - 121
  • [2] PHARMACOLOGY OF BINDING OF H-3 SCH-23390 TO D-1 DOPAMINERGIC RECEPTOR-SITES IN RAT STRIATAL TISSUE
    FAEDDA, G
    KULA, NS
    BALDESSARINI, RJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (03) : 473 - 480
  • [3] Effects of chronic ethanol treatment and ethanol withdrawal on [H-3]SCH23390 binding to rat striatal membranes
    GilMartin, E
    FernandezBriera, A
    Calvo, P
    [J]. NEUROPHARMACOLOGY, 1997, 36 (01) : 101 - 106
  • [4] BINDING OF [H-3] SCH-23390 TO DOPAMINE D-1 RECEPTORS IN RAT RETINA INVITRO
    GREDAL, O
    PARKINSON, D
    NIELSEN, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (2-3) : 241 - 245
  • [5] THE KINETICS OF [H-3] SCH-23390 DISSOCIATION FROM RAT STRIATAL DOPAMINE D-1 RECEPTORS - EFFECT OF DOPAMINE
    FARRELL, CB
    OBOYLE, KM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 268 (01): : 79 - 88
  • [6] ASCORBIC-ACID INHIBITS [H-3] SCH-23390 BINDING TO STRIATAL DOPAMINE-D1 RECEPTORS
    WIENER, HL
    LAJTHA, A
    SERSHEN, H
    [J]. JOURNAL OF RECEPTOR RESEARCH, 1989, 9 (4-5): : 331 - 339
  • [7] EVALUATION OF THE DOPAMINE (DA) D-1 RECEPTOR SELECTIVITY OF [H-3]SCH 23390 BINDING TO RAT STRIATAL MEMBRANES
    JARVIS, M
    STONE, G
    BISCHOFF, S
    WILLIAMS, M
    SILLS, M
    [J]. FASEB JOURNAL, 1988, 2 (05): : A1399 - A1399
  • [8] EFFECTS OF CHRONIC ANTIDEPRESSANT TREATMENT ON DOPAMINE-RELATED [H-3] SCH-23390 AND [H-3] SPIPERONE BINDING IN THE RAT STRIATUM
    PAETSCH, PR
    GREENSHAW, AJ
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1992, 12 (06) : 597 - 606
  • [9] CHARACTERIZATION OF [I-125] SCH-23982 BINDING IN HUMAN BRAIN - COMPARISON WITH [H-3] SCH-23390
    LARUELLE, M
    SIDHU, A
    CASANOVA, MF
    WEINBERGER, DR
    KLEINMAN, JE
    [J]. NEUROSCIENCE LETTERS, 1991, 131 (02) : 273 - 276
  • [10] DISPLACEMENT ACTIVITY OF BISBENZYLISOQUINOLINE ALKALOIDS AT STRIATAL H-3 SCH 23390 AND H-3 RACLOPRIDE BINDING-SITES
    CORTES, D
    FIGADERE, B
    SAEZ, J
    PROTAIS, P
    [J]. JOURNAL OF NATURAL PRODUCTS, 1992, 55 (09): : 1281 - 1286